Friday, August 31, 2012

ADA and GSK Award in the Microbiome and Metabolic Changes in Diabetes and Obesity

Description:

The American Diabetes Association and GlaxoSmithKline Award in the Microbiome and Metabolic Changes in Diabetes and Obesity are designed to support basic, translational and clinical research proposals focusing on the relationship between the microbiome and metabolism, including the role of the microbiome in the predisposition to and progression of obesity and diabetes.

Additional information:

http://professional.diabetes.org/Diabetes_Research.aspx?typ=18&cid=89698#GSK

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.